These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17326199)

  • 1. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998.
    Fuller CD; Wang SJ; Thomas CR; Hoffman HT; Weber RS; Rosenthal DI
    Cancer; 2007 Apr; 109(7):1331-43. PubMed ID: 17326199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.
    Choi M; Fuller CD; Thomas CR; Wang SJ
    Gynecol Oncol; 2008 May; 109(2):203-9. PubMed ID: 18329082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.
    Davis FG; McCarthy BJ; Freels S; Kupelian V; Bondy ML
    Cancer; 1999 Jan; 85(2):485-91. PubMed ID: 10023719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes for head and neck squamous cell carcinoma arising after lymphoma.
    Moore MG; Bhattacharyya N
    Otolaryngol Head Neck Surg; 2008 Mar; 138(3):388-93. PubMed ID: 18312890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
    Kao J; Lavaf A; Teng MS; Huang D; Genden EM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark.
    Skuladottir H; Olsen JH
    J Clin Oncol; 2003 Aug; 21(16):3035-40. PubMed ID: 12915592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional survival of patients with diffuse large B-cell lymphoma.
    Moller MB; Pedersen NT; Christensen BE
    Cancer; 2006 May; 106(10):2165-70. PubMed ID: 16586498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus in HNSCC: a European epidemiologic perspective.
    Licitra L; Zigon G; Gatta G; Sánchez MJ; Berrino F;
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1143-53, vii-viii. PubMed ID: 19010264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative lack of conditional survival improvement in young adults with cancer.
    Bleyer A; Choi M; Fuller CD; Thomas CR; Wang SJ
    Semin Oncol; 2009 Oct; 36(5):460-7. PubMed ID: 19835741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
    Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
    Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival.
    Italiano A; Ortholan C; Dassonville O; Poissonnet G; Thariat J; Benezery K; Vallicioni J; Peyrade F; Marcy PY; Bensadoun RJ
    Cancer; 2008 Dec; 113(11):3160-8. PubMed ID: 18932260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of islet cell carcinoma.
    Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
    Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
    Rusthoven KE; Raben D; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.